ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
3 ASX shares brokers have named as buys
Blue Chip Shares
2 excellent blue chip ASX 200 shares to buy this month
Growth Shares
3 buy-rated ASX shares
Share Market News
Here are the top 10 ASX shares today
Share Gainers
Why AnteoTech, BrainChip, City Chic, and ResMed shares are charging higher
Growth Shares
Analysts name 2 excellent ASX growth shares to buy right now
Broker Notes
Here's what this broker thinks of the ResMed (ASX:RMD) share price
Share Market News
5 things to watch on the ASX 200 on Monday
Growth Shares
3 buy-rated ASX growth shares
Broker Notes
Broker tips ResMed (ASX:RMD) share price to rise over 20%
Healthcare Shares
In the green: Here are the 5 best ASX healthcare shares of 2021
Growth Shares
3 top ASX growth shares to buy in January
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
